Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
We report the effectiveness of daratumumab, a human IgGκ monoclonal antibody targeting CD38 on plasma cells, for therapy-refractory antibody-mediated rejection (AMR) due to blood group antibodies in a 59-year-old man who received a living ABO-incompatible kidney transplantation. Standard treatment o...
Main Authors: | Davide Spica, Till Junker, Michael Dickenmann, Stefan Schaub, Jürg Steiger, Tanja Rüfli, Jörg Halter, Helmut Hopfer, Andreas Holbro, Patricia Hirt-Minkowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-11-01
|
Series: | Case Reports in Nephrology and Dialysis |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/503951 |
Similar Items
-
Progression of histological lesions after ABO incompatible kidney transplantation
by: Pierre Guy, et al.
Published: (2022-10-01) -
A comparative analysis of live-related ABO-incompatible and ABO-compatible renal transplantation: Effect of Vitamin D deficiency on antibody-mediated rejection - A retrospective observational study
by: Monika Yachha, et al.
Published: (2021-01-01) -
Significance of C4d expression in peritubular capillaries concurrent with microvascular inflammation in for-cause biopsies of ABO-incompatible renal allografts
by: Haeyon Cho, et al.
Published: (2024-01-01) -
Emergency, ABO-Incompatible Living Donor Liver Re-Transplantation for Graft Failure Complicated by Pneumonia-Associated Sepsis
by: Seoung Hoon Kim, et al.
Published: (2023-01-01) -
Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients
by: Ignjatović Ljiljana, et al.
Published: (2009-01-01)